Transforming growth factor-β1 gene and protein expression associated with atherogenesis of cholesterol-fed rabbits

Histology and Histopathology

Volumn 15, Issue 2, 2000, Pages 421-428

  Chen, Y L ^a   Wu, H W ^a   Jiang, Mee Jyh ^b  

^a NATIONAL YANG MING UNIVERSITY   (Taiwan)

^b NATIONAL CHENG KUNG UNIVERSITY   (Taiwan)

Author keywords

Atherogenesis; Fibronectin; Immunohistochemistry; In situ hybridization; Transforming growth factor 1

Indexed keywords

CHOLESTEROL; FIBRONECTIN; MESSENGER RNA; TRANSFORMING GROWTH FACTOR BETA1;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ATHEROGENESIS; ATHEROSCLEROTIC PLAQUE; CONTROLLED STUDY; GENE EXPRESSION; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; NONHUMAN; PROTEIN EXPRESSION; RABBIT;

ANIMALS; AORTA; ARTERIOSCLEROSIS; CHOLESTEROL, DIETARY; FEEDING BEHAVIOR; FIBRONECTINS; HUMANS; HYPERCHOLESTEROLEMIA; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; MALE; RABBITS; TRANSFORMING GROWTH FACTOR BETA;

ANIMALIA; ORYCTOLAGUS CUNICULUS;

EID: 0034002561     PISSN: 02133911     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. Aliev G. and Burnstock G. (1998). Watanabe rabbits with heritable hypercholesterolaemia: a model of atherosclerosis. Histol. Histopathol. 13, 797-817.
2. Aqel N.M., Ball R.Y., Waldmann H. and Mitchinson M.J. (1985). Identification of macrophages and smooth muscle cells in human atherosclerosis using monoclonal antibodies. J. Pathol. 146, 197-204.
3. Ardinger H.H., Ardinger R.H., Bell G.I. and Murray J.C. (1988). RFLP for the human transforming growth factor beta-1 gene (TGFβ) on chromosome 19. Nucleic. Acids Res. 16, 8202.
4. Balza E., Borsi L., Allemanni G. and Zardi L. (1988). Transforming growth factor β regulates the levels of different fibronectin isoforms in normal human cultured fibroblasts. FEBS Lett. 228, 42-44.
5. Borkowski P., Robinson M.J., Kusiak J.W., Borkowski A., Brathwaite C. and Mergner W.J. (1995). Studies on TGF-β1 gene expression in the intima of the human aorta in regions with high and low probability of developing atherosclerotic lesions. Modern Pathol. 8, 478-482.
6. Chen J.K., Hoshi H. and Mckeehan W.L. (1987). Transforming growth factor type β specifically stimulates synthesis of proteoglycan in human adult arterial smooth muscle cells. Proc. Natl. Acad. Sci. USA 84, 5287-5291.
7. Chen Y.L., Chang Y.J. and Jiang M.J. (1999). Monocyte chemotactic protein-1 gene and protein expression in atherogenesis of hypercholesterolemic rabbits. Atherosclerosis 143, 115-123.
8. Edwards D.R., Murphy G., Reynolds J.J., Whitham S.E., Docherty A.J.P., Angel P. and Heath J.K. (1987). Transforming growth factor-β modulates the expression of collagenase and metalloproteinase inhibitor. EMBO J. 6, 1899-1904.
9. Faggiotto A., Ross R. and Harker L. (1984). Studies of hyper-cholesterolemia in the nonhuman primate. I. Changes that lead to fatty streak formation. Arteriosclerosis 4, 323-340.
10. Grainger D.J., Kemp P.R., Witchell C.M., Weissberg P.L. and Metcalfe J.C. (1994). Transforming growth factor β decreases the rate of proliferation of rat vascular smooth muscle cells by extending the G2 phase of the cell cycle and delays the rise in cyclic AMP before entry into M phase. Biochem. J. 299, 227-235.
11. Halloran B.G., Prorok G.D., So B.J. and Baxter B.T. (1995). Transforming growth factor-β1 inhibits human arterial smooth-muscle cell proliferation in a growth-rate-dependent manner. Am. J. Surg. 170, 193-197.
12. Jayo J.M., Schwenke D.C. and Clarkson T.B. (1994). Atherosclerosis research. In: The biology of the laboratory rabbit. 2nd ed. Manning P.J., Ringler D.H. and Newcomer C.E. (eds). Academic Press, pp 367-380.
13. Kanzaki T., Tamura K., Takahashi K., Saito Y., Akikusa B., Oohashi H., Kasayuki N., Ueda M. and Morisaki N. (1995). In vivo effect of TGF-β1: Enhanced intimai thickening by administration of TGF-β1 in rabbit arteries injured with a balloon catheter. Arterioscler. Thromb. Vasc. Biol. 15, 1951-1957.
14. Lawrence R., Hartmann D.J. and Sonenshein G.E. (1994). Transforming growth factor β1 stimulates type V collagen expression in bovine vascular smooth muscle cells. J. Biol. Chem. 269, 9603-9609.
15. Liptay M.J., Parks W.C., Mecham R.P., Roby J., Kaiser L.R., Cooper J.D. and Botney M.D. (1993). Neointimal macrophages colocalize with extracellular matrix gene expression in human atherosclerotic pulmonary arteries. J. Clin. Invest. 91, 588-594.
16. Lopez-Candales A., Scott M.J. and Wickline S.A. (1995). Cholesterol feeding modulates spatial expression of TGF-β1 and β2 in aortas of Watanabe rabbits. Cytokine 7, 554-561.
17. Majesky M.W., Lindner V., Twardzik D.R., Schwartz S.M. and Reidy M.A. (1991). Production of transforming growth factor β1 during repair of arterial injury. J. Clin. Invest. 88, 904-910.
18. Mii S., Ware J.A. and Kent K.C. (1993). Transforming growth factor-beta inhibits human vascular smooth muscle cell growth and migration. Surgery 114, 464-470.
19. Nabel E.G., Shum L., Pompili V.J., Yang Z.Y., San H., Shu H.B., Liptay S., Gold L., Gordon D., Derynck R. and Nabel G.J. (1993). Direct transfer of transforming growth factor β1 gene into arteries stimulates fibrocellular hyperplasia. Proc. Natl. Acad. Sci. USA 90, 10759-10763.
20. Nikol S., Isner J.M., Pickering J.G., Kearney M., Leclerc G. and Weir L. (1992). Expression of transforming growth factor-β1 is increased in human vascular restenosis lesions. J. Clin. Invest. 90, 1582-1592.
21. Pang J.H.S., Jiang M.J., Chen Y.L., Wang F.W., Wang D.L., Chu S.H. and Chau L.Y. (1996). Increased ferritin gene expression in atherosclerotic lesions. J. Clin. Invest. 97, 2204-2212.
22. Ross R. (1993). The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature 362, 801-809.
23. Sassoon D. and Rosenthal N. (1993). Detection of messenger RNA by in situ hybridization. In: Methods in enzymology. Vol. 225. Wassarman P.M. and DePamphilis M.L. (eds). Academic Press. pp 384-404.
24. Schonherr E., Jarvelainen H.T., Sandell L.J. and Wight T.N. (1991). Effects of platelet-derived growth factor and transforming growth factor-β1 on the synthesis of a large versican-like chondroitin sulfate proteoglycan by arterial smooth muscle cells. J. Biol. Chem. 266, 17640-17647.
25. Scott L., Kerr A., Haydock D. and Merrilees M. (1997). Subendothelial proteoglycan synthesis and transforming growth factor beta distribution correlates with susceptibility to atherosclerosis. J. Vasc. Res. 34, 365-377.
26. Shull M.M., Ormsby L., Kier A.B., Pawlowski S., Diebold R.J., Yin M., Allen R., Sidman C., Proetzel G., Calvin D., Annunziata N. and Doetschman T. (1992). Targeted disruption of the mouse transforming growth factor-β1 gene results in multifocal inflammatory disease. Nature 359, 693-699.
27. Sporn M.B., Roberts A.B., Wakefield L.M. and Assoian P.K. (1986). Transforming growth factor-β: biological function and chemical structure. Science 233, 532-534.
28. Stary H.C., Blankenhorn D.H., Chandler A.B., Glagov S., Insull W. Jr., Richardson M., Rosenfeld M.E., Schaffer S.A., Schwartz C.J., Wagner W.D. and Wissler R.W. (1992). A definition of the intima of human arteries and of its atherosclerosis-prone regions. Arterioscler. Thromb. 12, 120-134.
29. Thyberg J. (1998). Phenotypic modulation of smooth muscle cells during formation of neointimal thickenings following vascular injury. Histol. Histopathol. 13, 871-891.
30. Wahl S.M., Hunt D.A., Wakefield L.M., McCartney-Francis N., Wahl L.M., Roberts A.B. and Sporn M.B. (1987). Transforming growth factor β induces monocyte chemotaxis and growth factor production. Proc. Natl. Acad. Sci. USA 84, 5788-5792.
31. Wiseman D.M., Polverini P.J., Kamp D.W., Leibovich S.J. (1988). Transforming growth factor-beta (TGFβ) is chemotactic for human monocytes and induces their expression of angiogenic activity. Biochem. Biophys. Res. Commun. 157, 793-800.
32. Wolf Y.G., Rasmussen L.M. and Ruoslahti E. (1994). Antibodies against transforming growth factor-β1 suppress intimai hyperplasia in a rat model. J. Clin. Invest. 93, 1172-1178.
33. Wysocki S.J., Zheng M.H., Fan Y., Lamawansa M.D., House A.K. and Norman P.E. (1996). Expression of transforming growth factor-β1 (TGF-β1) and urokinase-type plasminogen activator (u-PA) genes during arterial repair in the pig. Cardiovasc. Res. 31, 28-36.